Free Trial
NASDAQ:PTIX

Atrinsic (PTIX) Stock Price, News & Analysis

Atrinsic logo
$3.40 -0.09 (-2.44%)
Closing price 07/3/2025 03:59 PM Eastern
Extended Trading
$3.42 +0.02 (+0.74%)
As of 07/3/2025 04:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Atrinsic Stock (NASDAQ:PTIX)

Key Stats

Today's Range
$3.33
$3.55
50-Day Range
$2.85
$11.10
52-Week Range
$2.35
$15.54
Volume
140,794 shs
Average Volume
571,910 shs
Market Capitalization
$2.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Atrinsic Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
12th Percentile Overall Score

PTIX MarketRank™: 

Atrinsic scored higher than 12% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Atrinsic.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Atrinsic is -0.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Atrinsic is -0.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Atrinsic has a P/B Ratio of 1.73. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Atrinsic's valuation and earnings.
  • Percentage of Shares Shorted

    3.77% of the float of Atrinsic has been sold short.
  • Short Interest Ratio / Days to Cover

    Atrinsic has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Atrinsic has recently decreased by 27.17%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Atrinsic does not currently pay a dividend.

  • Dividend Growth

    Atrinsic does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.77% of the float of Atrinsic has been sold short.
  • Short Interest Ratio / Days to Cover

    Atrinsic has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Atrinsic has recently decreased by 27.17%, indicating that investor sentiment is improving significantly.
  • Search Interest

    Only 4 people have searched for PTIX on MarketBeat in the last 30 days. This is a decrease of -60% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Atrinsic insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    35.00% of the stock of Atrinsic is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 7.97% of the stock of Atrinsic is held by institutions.

  • Read more about Atrinsic's insider trading history.
Receive PTIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Atrinsic and its competitors with MarketBeat's FREE daily newsletter.

PTIX Stock News Headlines

Protagenic Therapeutics, Inc. (PTIX) - Yahoo Finance
Have you heard of “E.I.”?
Inside Expert: New "E.I." Tech Could Be Poised For 200,000% Growth Meta, Apple, and even NASA are rushing to invest in new "E.I." Tech, which one expert estimates will grow by 200,000%. Becoming bigger than the automobile, PC, and cell phone markets... COMBINED!
Protagenic Therapeutics swaps warrants for shares
See More Headlines

PTIX Stock Analysis - Frequently Asked Questions

Atrinsic's stock was trading at $6.86 at the beginning of the year. Since then, PTIX shares have decreased by 50.5% and is now trading at $3.3950.

Atrinsic Inc. (NASDAQ:PTIX) released its quarterly earnings results on Tuesday, May, 13th. The company reported ($2.75) earnings per share for the quarter.

Atrinsic's stock reverse split before market open on Monday, May 5th 2025.A 1-14 reverse split was announced. The number of shares owned by shareholders was adjusted after the market closes on Sunday, May 4th 2025. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Shares of PTIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Atrinsic investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), NVIDIA (NVDA), Cytokinetics (CYTK), Heatwurx (PCSA), Acasti Pharma (ACST) and Akero Therapeutics (AKRO).

Company Calendar

Last Earnings
5/13/2025
Today
7/04/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:PTIX
Employees
2
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$5.53 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$1.96 per share
Price / Book
1.73

Miscellaneous

Free Float
383,000
Market Cap
$2.00 million
Optionable
Not Optionable
Beta
0.34
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (NASDAQ:PTIX) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners